Sustained virologic response to peginterferon α-2a and ribavirin in 335 patients with chronic hepatitis C: A tertiary care center experience
Open Access
- 1 January 2008
- journal article
- research article
- Published by Medknow in Saudi Journal of Gastroenterology
- Vol. 14 (2) , 58-65
Abstract
Official Journal of Saudi Gastroenterology Association.Keywords
This publication has 40 references indexed in Scilit:
- IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infectionHepatology, 2006
- Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis CBlood, 2005
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- NIH Consensus Statement on Management of Hepatitis C: 2002.2004
- Regression of hepatic fibrosis and cirrhosis in patients with chronic hepatitis C treated with interferon-based therapyGastroenterology, 2003
- Treatment of Hepatitis C Virus Genotype 4–Related CirrhosisJournal of Clinical Gastroenterology, 2002
- Infection with Hepatitis C Virus Genotype 4 Is Associated with a Poor Response to Interferon-αAnnals of Internal Medicine, 2001
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 2001
- Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microgliaGlia, 2000
- Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients.1999